Antidiabetic activity of the aqueous extract of Erigeron floribundus leaves in streptozotocin-induced type 1 diabetes model in Wistar rats

Boutou Masky , Hamadjida Adjia , David Miaffo , Bibi Farouck Aboubakar Oumarou , Harquin Simplice Foyet , Kakesse Maguirgue , Ernest Rodrigue Talla , Angele Kopodjing Bello , Christian Bonabé , Fidèle Ntchapda
{"title":"Antidiabetic activity of the aqueous extract of Erigeron floribundus leaves in streptozotocin-induced type 1 diabetes model in Wistar rats","authors":"Boutou Masky ,&nbsp;Hamadjida Adjia ,&nbsp;David Miaffo ,&nbsp;Bibi Farouck Aboubakar Oumarou ,&nbsp;Harquin Simplice Foyet ,&nbsp;Kakesse Maguirgue ,&nbsp;Ernest Rodrigue Talla ,&nbsp;Angele Kopodjing Bello ,&nbsp;Christian Bonabé ,&nbsp;Fidèle Ntchapda","doi":"10.1016/j.metop.2024.100288","DOIUrl":null,"url":null,"abstract":"<div><h3>Backgroud</h3><p><em>Erigeron floribundus</em> is a herbaceous plant used in traditional Cameroonian medicine to treat diabetes mellitus. The aim of this study was to evaluate the antidiabetic properties of the aqueous extract of <em>E. floribundus</em> leaves (AEEF) in diabetic rats.</p></div><div><h3>Methods</h3><p>Diabetes was induced by a single intraperitoneal injection of streptozotocin (60 mg/kg) in normal rats fasted for 16 h. Subsequently, 30 diabetic male rats were divided into groups and treated orally for 21 days with distilled water (10 mL/kg), glibenclamide (3 mg/kg) and AEEF (300, 400, and 500 mg/kg). Body weight, food and water intake, blood glucose, insulin levels, lipid and oxidative profiles, as well as some markers of liver and kidney function were assessed. Histological sections of the rats' pancreas were taken.</p></div><div><h3>Results</h3><p>AEEF and glibenclamide significantly increased (p &lt; 0.001) body weight and decreased food and water intake in rats. A decrease in blood glucose (p &lt; 0.001) and an increase in insulin levels (p &lt; 0.001) were observed in the AEEF and glibenclamide groups. AEEF caused a significant (p &lt; 0.001) decrease in the levels of total cholesterol, LDL-c, triglycérides and coronary risk index (CRI), accompanied by a significant (p &lt; 0.001) increase in HDL levels and HOMA-β in rats. AEEF showed an improvement (p &lt; 0.001) in CAT and SOD activity and GSH levels accompanied by a significant decrease (p &lt; 0.001) in malondialdehyde levels. In addition, ALAT and ASAT activity, urea and creatinine levels were significantly reduced (p &lt; 0.001) after treatment with AEEF and glibenclamide. The extract also improved the size of Langerhans Islets in the pancreas of diabetic rats.</p></div><div><h3>Conclusion</h3><p>AEEF contains several bioactive compounds conferring antidiabetic, anti-dyslipidemic and antioxidant properties, thus justifying its therapeutic use in the treatment of diabetes mellitus.</p></div>","PeriodicalId":94141,"journal":{"name":"Metabolism open","volume":"22 ","pages":"Article 100288"},"PeriodicalIF":0.0000,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589936824000203/pdfft?md5=22b5e81aeb49ac294a27975b00ff4ad9&pid=1-s2.0-S2589936824000203-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolism open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589936824000203","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Backgroud

Erigeron floribundus is a herbaceous plant used in traditional Cameroonian medicine to treat diabetes mellitus. The aim of this study was to evaluate the antidiabetic properties of the aqueous extract of E. floribundus leaves (AEEF) in diabetic rats.

Methods

Diabetes was induced by a single intraperitoneal injection of streptozotocin (60 mg/kg) in normal rats fasted for 16 h. Subsequently, 30 diabetic male rats were divided into groups and treated orally for 21 days with distilled water (10 mL/kg), glibenclamide (3 mg/kg) and AEEF (300, 400, and 500 mg/kg). Body weight, food and water intake, blood glucose, insulin levels, lipid and oxidative profiles, as well as some markers of liver and kidney function were assessed. Histological sections of the rats' pancreas were taken.

Results

AEEF and glibenclamide significantly increased (p < 0.001) body weight and decreased food and water intake in rats. A decrease in blood glucose (p < 0.001) and an increase in insulin levels (p < 0.001) were observed in the AEEF and glibenclamide groups. AEEF caused a significant (p < 0.001) decrease in the levels of total cholesterol, LDL-c, triglycérides and coronary risk index (CRI), accompanied by a significant (p < 0.001) increase in HDL levels and HOMA-β in rats. AEEF showed an improvement (p < 0.001) in CAT and SOD activity and GSH levels accompanied by a significant decrease (p < 0.001) in malondialdehyde levels. In addition, ALAT and ASAT activity, urea and creatinine levels were significantly reduced (p < 0.001) after treatment with AEEF and glibenclamide. The extract also improved the size of Langerhans Islets in the pancreas of diabetic rats.

Conclusion

AEEF contains several bioactive compounds conferring antidiabetic, anti-dyslipidemic and antioxidant properties, thus justifying its therapeutic use in the treatment of diabetes mellitus.

花叶二igeron 水提取物在链脲佐菌素诱导的 Wistar 大鼠 1 型糖尿病模型中的抗糖尿病活性
背景:Erigeron floribundus 是一种草本植物,在喀麦隆传统医学中用于治疗糖尿病。本研究的目的是评估 E. floribundus 叶的水提取物(AEEF)在糖尿病大鼠中的抗糖尿病特性。随后,将 30 只雄性糖尿病大鼠分成几组,分别口服蒸馏水(10 mL/kg)、格列本脲(3 mg/kg)和 AEEF(300、400 和 500 mg/kg)治疗 21 天。对大鼠的体重、食物和水摄入量、血糖、胰岛素水平、血脂和氧化谱以及肝肾功能的一些指标进行了评估。结果 AEEF 和格列本脲能显著增加(p < 0.001)大鼠的体重,减少食物和水的摄入量。在 AEEF 组和格列本脲组观察到血糖降低(p < 0.001)和胰岛素水平升高(p < 0.001)。AEEF 使大鼠的总胆固醇、低密度脂蛋白胆固醇(LDL-c)、甘油三酯(triglycérides)和冠状动脉风险指数(CRI)水平显著下降(p < 0.001),同时高密度脂蛋白(HDL)水平和 HOMA-β 显著上升(p < 0.001)。AEEF 表明 CAT 和 SOD 活性以及 GSH 水平有所提高(p < 0.001),同时丙二醛水平显著降低(p < 0.001)。此外,经 AEEF 和格列本脲处理后,ALAT 和 ASAT 活性、尿素和肌酐水平均明显降低(p < 0.001)。结论 AEEF 含有多种生物活性化合物,具有抗糖尿病、抗血脂异常和抗氧化的特性,因此可用于治疗糖尿病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Metabolism open
Metabolism open Agricultural and Biological Sciences (General), Endocrinology, Endocrinology, Diabetes and Metabolism
自引率
0.00%
发文量
0
审稿时长
40 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信